Cargando…

Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19

A commentary on “Humoral immune response to SARS-CoV-2 in Iceland”.

Detalles Bibliográficos
Autores principales:	Zhang, Kang, Ma, Zhen-Guo, Yang, Lei, Kang, Wei, Yin, Yun, Lau, Johnson Yiu-Nam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717369/ https://www.ncbi.nlm.nih.gov/pubmed/35693124 http://dx.doi.org/10.1093/pcmedi/pbaa036

Ejemplares similares

SARS-CoV-2 reinfection in two patients who have recovered from COVID-19
por: Zhang, Kang, et al.
Publicado: (2020)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

Estimated prevalence and viral transmissibility in subjects with asymptomatic SARS-CoV-2 infections in Wuhan, China
por: Zhang, Kang, et al.
Publicado: (2020)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021)

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis
por: Martin, Paul, et al.
Publicado: (2021)

Age-Related Differences in Immunological Responses to SARS-CoV-2
por: Wong, Lydia Su Yin, et al.
Publicado: (2020)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

The diagnosis of SARS-CoV-2 associated ADEM requires the exclusion of all differential diagnoses
por: Finsterer, Josef, et al.
Publicado: (2022)

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2022)

The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera
por: Li, Gen, et al.
Publicado: (2021)

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
por: Zhao, Lei, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review
por: Zuin, Marco, et al.
Publicado: (2023)

Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
por: Bordry, Natacha, et al.
Publicado: (2021)

Hair and Humor - 1 - “The Only Problem”
por: Pai, Ganesh S
Publicado: (2019)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

In SARS-CoV-2, astrocytes are in it for the long haul
por: Huang, Shuhan, et al.
Publicado: (2022)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

What Is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine in Wuhan City, China
por: Zhang, Lei, et al.
Publicado: (2020)

Humoral Immune Response to SARS-CoV-2 in Iceland
por: Gudbjartsson, Daniel F., et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

SARS-CoV-2 and human reproduction: An open question
por: Entezami, Frida, et al.
Publicado: (2020)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

Evolutionary medical insights into the SARS-CoV-2 pandemic
por: Crespi, Bernard
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

SARS-CoV-2 and the skin, a hidden treasure
por: Gianotti, Raffaele
Publicado: (2020)

Preventing the introduction of SARS-CoV-2 into school settings
por: Thampi, Nisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9e864p61647tbkmtr5sfr5fa9